Description

CPN-219, a next-generation hexapeptidic NMUR2 agonist, achieves a dose-dependent and selective activation of NMUR2 with an EC50 value of 2.2 nM[1].—–C40H72N12O8—-[1]Kentaro Takayama, et al. A chemically stable peptide agonist to neuromedin U receptor type 2. Bioorg Med Chem. 2020 May 15;28(10):115454.–2240202-02-0–849.08—-O=C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCN)C(N1[C@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(N)=O)C(N)=O)=O)=O)CCC1)=O)=O)=O)CCC2CCCCC2–Inflammation/Immunology–10 mM in DMSO–Others—-Others–Peptides